Press-release for stocks related to earnings for abbv

tags : Earnings symbols : Abbv

save search

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| -4.64% | O: 0.48% H: 1.56% C: 1.48%
IRWD | $7.94 4.47% 4.28% 2.5M

Health Technology

| -50.81% | O: -5.63% H: 7.34% C: 2.81%
year pharmaceuticals ironwood financial

AbbVie Reports Third-Quarter 2023 Financial Results
Published: 2023-10-27 (Crawled : 20:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 14.24% | O: -4.81% H: 0.0% C: 0.0%
abbvie financial results

AbbVie Reports Second-Quarter 2023 Financial Results
Published: 2023-07-27 (Crawled : 15:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 16.75% | O: 2.13% H: 4.77% C: 3.02%
abbvie financial results

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023
Published: 2023-05-11 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 12.8% | O: 0.59% H: 0.19% C: -0.48%
SMMT A | $3.51 0.0% 1.7M

Health Technology

| 68.4% | O: 0.47% H: 0.47% C: -9.62%
therapeutics financial results

AbbVie to Host First-Quarter 2023 Earnings Conference Call
Published: 2023-04-04 (Crawled : 18:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 2.95% | O: 0.06% H: 0.76% C: -0.45%
conference abbvie

AbbVie Reports Full-Year and Fourth-Quarter 2022 Financial Results
Published: 2023-02-09 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 14.21% | O: 2.69% H: 3.5% C: 0.13%
abbvie financial results

AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call
Published: 2023-01-05 (Crawled : 17:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 0.9% | O: -0.37% H: 0.86% C: 0.25%
conference

Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance
Published: 2022-11-03 (Crawled : 12:20) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 14.28% | O: -0.36% H: 0.99% C: 0.29%
IRWD | $7.94 4.47% 4.28% 2.5M

Health Technology

| -30.66% | O: 2.92% H: 1.42% C: 0.71%
pharmaceuticals year financial

Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand
Published: 2022-08-04 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 16.57% | O: 0.29% H: 0.34% C: -2.23%
IRWD | $7.94 4.47% 4.28% 2.5M

Health Technology

| -32.2% | O: -0.98% H: 3.78% C: 3.42%
linzess year

Pfizer Reports First-Quarter 2022 Results
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -47.06% | O: 1.77% H: 2.39% C: 0.86%
BHVN | $38.99 -7.52% 0.0% 3.4M

Health Technology

| -52.79% | O: 4.37% H: 0.98% C: -3.34%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 11.8% | O: 0.89% H: 0.0% C: 0.0%
SGMO | $0.5143 6.02% 5.68% 1M

Health Technology

| -87.44% | O: 7.97% H: 2.91% C: 0.0%
OPK | $1.23 0.0% 2.7M

Health Technology

| -54.78% | O: 2.94% H: 4.64% C: 3.21%
BNTX | $86.82 0.75% 0.75% 1.6M

Health Technology

| -39.25% | O: 3.06% H: 3.6% C: 2.08%
BEAM | $23.9 -1.69% -1.72% 4.5M

Health Technology

| -31.61% | O: 8.78% H: 3.69% C: -2.08%
results

Off to Stratospheric 2022 Start, AbbVie Announces New Protein Degradation Partnership
Published: 2022-04-28 (Crawled : 15:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 5.76% | O: 0.6% H: 0.0% C: 0.0%
partnership

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2021
Published: 2022-02-17 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 13.22% | O: -0.73% H: 0.46% C: 0.12%
IRWD | $7.94 4.47% 4.28% 2.5M

Health Technology

| -30.91% | O: -3.64% H: 1.32% C: 0.09%
linzess sales als report results

AbbVie Leans on Skyrizi, Rinvoq as Humira Rides off the Patent Cliff
Published: 2022-02-02 (Crawled : 21:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 20.41% | O: -1.94% H: 0.0% C: 0.0%
patent skyrizi humira rinvoq

AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results
Published: 2022-02-02 (Crawled : 14:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 20.41% | O: -1.94% H: 0.0% C: 0.0%
IMAB | $1.81 0.56% 0.55% 340K

Health Technology

| -92.87% | O: 5.41% H: 0.0% C: 0.0%
financial results report results

Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 22.15% | O: -0.37% H: 0.0% C: 0.0%
IRWD | $7.94 4.47% 4.28% 2.5M

Health Technology

| -35.92% | O: -3.79% H: 4.65% C: 4.29%

AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call
Published: 2022-01-05 (Crawled : 15:30) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 22.02% | O: -0.01% H: 0.0% C: 0.0%
conference